Insight
Scaling the Science
Discover how IQVIA Laboratories Biosciences successfully managed a large-scale comparative bioavailability/bioequivalence program involving more than 45,000 pharmacokinetic (PK) samples while meeting aggressive regulatory timelines. This case study highlights the scientific expertise, operational planning, and proactive problem-solving that enabled a 98% first-time pass rate, timely data delivery, and a submission-ready dataset, demonstrating how complex bioanalytical challenges can be transformed into reliable, high-quality results.
Download Document
Related Insights
Managing Informed Consent Samples from Clinical Trials
A set of best practices for the definition, tracking and management of allowable use attributes associated with samples collected in protocol based clinical trials
Biorepository and Specimen Management
Your biological specimens are irreplaceable assets – trust them with a proven partner
ADME Services
Accelerating your drug discovery, preclinical and clinical programs
IQVIA Laboratories Central Laboratory Services
Central laboratory solutions supporting clinical trials around the world
Helping you master your lab data
Improved oversight with your lab data now in full view
MASH and Liver Disease Capabilities
How COVID-19 Changed Clinical Trial Dynamics and Environment
Precision Medicine World Conference 2021 Virtual Presentation
Pediatric Initiative
Optimizing small blood volumes to prevent canceled tests in clinical trials for pediatric patients
Vaccine Laboratory Services
Test Menu
SARS-CoV-2 Vaccine Induced Antibody Profiles
Presented at World Vaccine Congress 2021
